Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024

Rhea-AI Summary

Bristol Myers Squibb (BMY) will release its Q4 2023 results on February 2, 2024, with a conference call for investors and analysts at 8:00 a.m. ET. The live webcast can be accessed at http://investor.bms.com, and materials will be available prior to the call. A replay will also be available on the same website.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) will announce results for the fourth quarter of 2023 on Friday, February 2, 2024. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Investors and the public can register for the live conference call here. Those unable to register can access the live conference call by dialing in the U.S. toll free 1-833-816-1116 or international +1 412-317-0705. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on February 2, 2024, through 11:30 a.m. ET on February 16, 2024, by dialing in the U.S. toll free 1-877-344-7529 or international +1 412-317-0088, conference code: 1212122.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20231215156427/en/

Media: media@bms.com

Investors: investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When will Bristol Myers Squibb (BMY) release its Q4 2023 results?

Bristol Myers Squibb (BMY) will release its Q4 2023 results on February 2, 2024.

What time will the conference call for investors and analysts begin?

The conference call for investors and analysts will begin at 8:00 a.m. ET on February 2, 2024.

Where can investors and the public access the live webcast of the call?

Investors and the public can access the live webcast of the call at http://investor.bms.com.

How can investors and the public register for the live conference call?

Investors and the public can register for the live conference call at http://investor.bms.com.

Where will materials related to the call be available?

Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.

When will the replay of the webcast be available?

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.

How long will the replay of the conference call be available?

A replay of the conference call will be available from 11:30 a.m. ET on February 2, 2024, through 11:30 a.m. ET on February 16, 2024, at http://investor.bms.com.